simendan has been researched along with Drug Overdose in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurola, J; Rapola, J; Sallisalmi, M; Varpula, T | 1 |
Graudins, A | 1 |
Kiviniemi, V; Kurola, J; Leppikangas, H; Lindgren, L; Ruokonen, E; Rutanen, J | 1 |
Başaranoğlu, G; Erkalp, K; Ozdemir, H; Saidoglu, L; Teker, MG | 1 |
4 other study(ies) available for simendan and Drug Overdose
Article | Year |
---|---|
Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer.
Topics: Acidosis, Lactic; Amlodipine; Calcium Channel Blockers; Cardiotonic Agents; Coma; Drug Overdose; Echocardiography; Epinephrine; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Verapamil | 2009 |
Letter regarding levosimendan in a rat model of severe verapamil poisoning.
Topics: Animals; Antidotes; Cardiotonic Agents; Cardiovascular Agents; Disease Models, Animal; Drug Overdose; Hemodynamics; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Rats; Severity of Illness Index; Simendan; Vasodilator Agents; Verapamil | 2009 |
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Overdose; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Random Allocation; Simendan; Survival Analysis; Swine | 2009 |
Levosimendan as a rescue adjunct in amlodipine intoxication--a case report.
Topics: Adolescent; Adrenergic alpha-Agonists; Amlodipine; Antidotes; Calcium Channel Blockers; Calcium Chloride; Cardiotonic Agents; Charcoal; Crystalloid Solutions; Dopamine; Drug Overdose; Female; Gastric Lavage; Humans; Hydrazones; Insulin; Isotonic Solutions; Norepinephrine; Pyridazines; Simendan; Treatment Outcome | 2010 |